SLC5A2 and diabetes mellitus: SGLT-2 inhibitors increase the risk of ketoacidosis due to diabetes (odds ratio 2.07, 95% confidence interval 1.44 to 2.98; high certainty); other drugs do not (high to very low certainty; fig 3 and appendix 5).